Cipla Gulf and Alvotech Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand
Gulf FZ LCC ( Cipla Gulf ), subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as Cipla and biopharmaceutical company Alvotech today announced that they are expanding their partnership for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.
As part of this strategic alliance, Cipla Gulf will be responsible for commercialization of patented biosimilars of leading products covering therapeutic categories across immunology, osteoporosis, oncology as well as ophthalmology.
The products are developed and manufactured by Alvotech and will be distributed by Cipla Gulf through Australia and New Zealand distribution networks. These innovative products recorded US$700 Mn in aggregate 2020 sales in Australia.
Cipla Gulf and Alvotech Expand Partnership for Commercialization of Biosimilars in Australia and New
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Cipla Gulf and Alvotech Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Cipla to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 12, 2021 GMT
Cipla Logo.
MUMBAI, India, Jan. 12, 2021 /PRNewswire/ Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as “Cipla” today announced that it will participate at the 39th Annual J.P. Morgan Healthcare Conference, which is the largest healthcare investment symposium in the industry.
Mr. Umang Vohra, MD and Global CEO, Cipla, will virtually present a corporate overview of the Company outlining its performance and progress in line with its identified strategic priorities to the investor community on Tuesday, January 12, 2021 (22.40 Hrs IST, 12:10 Hrs ET, 17.10 Hrs BST) and Wednesday, January 13, 2021 at 1.10 Hrs SST/HKT.
Cipla Announces Settlement of REVLIMID® (lenalidomide) Capsules Patent Litigation
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.